×
验证码:
换一张
Forgotten Password?
Stay signed in
China Science and Technology Network Pass Registration
×
China Science and Technology Network Pass Registration
Log In
Chinese
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
Log In
Register
ALL
ORCID
Title
Creator
Subject Area
Keyword
Document Type
Source Publication
Indexed By
Publisher
Date Issued
Date Accessioned
Funding Project
MOST Discipline Catalogue
Study Hall
Image search
Paste the image URL
Home
Collections
Authors
DocType
Subjects
K-Map
News
Search in the results
Collection
Authors
Zhang Tao [2]
Wang Wei [2]
Zhao Qun [1]
Zhang Wen [1]
Date Issued
2022 [2]
2021 [4]
Language
英语 [6]
Source Publication
JOURNAL OF... [3]
BRITISH JO... [1]
JAMA ONCOL... [1]
LIVER CANC... [1]
Funding Project
Jiangsu He... [2]
CAMS Innov... [1]
Capital He... [1]
Jiangsu He... [1]
National N... [1]
Non-profit... [1]
More...
Funding Organization
Jiangsu He... [2]
CAMS Innov... [1]
Capital He... [1]
Jiangsu He... [1]
National N... [1]
Non-profit... [1]
More...
Indexed By
SCI [6]
Abstract
Document Type
Journal ar... [6]
×
Knowledge Map
HFCAS OpenIR
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
QQ
Weibo
Feedback
Browse/Search Results:
1-6 of 6
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Author Ascending
Author Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
期刊论文
BRITISH JOURNAL OF CANCER, 2022
Authors:
Qin, Shukui
;
Li, Jin
;
Zhong, Haijun
;
Jin, Chuan
;
Chen, Lili
;
Yuan, Xianglin
;
Fan, Qingxia
;
Chen, Kehe
;
Cao, Peiguo
;
Xiao, Jianjun
;
Jiang, Da
;
Zhang, Tao
;
Zhang, Hongyu
;
Wang, Xicheng
;
Wang, Wei
;
Han, Lin
;
Wang, Qingyu
;
Zhu, Jun
Favorite
  |  
View/Download:7/0
  |  
Submit date:2022/12/22
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements
期刊论文
LIVER CANCER, 2022, 卷号: 11
Authors:
Sun, Yongkun
;
Zhang, Wen
;
Bi, Xinyu
;
Yang, Zhengqiang
;
Tang, Yu
;
Jiang, Liming
;
Bi, Feng
;
Chen, Minshan
;
Cheng, Shuqun
;
Chi, Yihebali
;
Han, Yue
;
Huang, Jing
;
Huang, Zhen
;
Ji, Yuan
;
Jia, Liqun
;
Jiang, Zhichao
;
Jin, Jing
;
Jin, Zhengyu
;
Li, Xiao
;
Li, Zhiyu
;
Liang, Jun
;
Liu, Lianxin
;
Liu, Yunpeng
;
Lu, Yinying
;
Lu, Shichun
;
Meng, Qinghua
;
Niu, Zuoxing
;
Pan, Hongming
;
Qin, Shukui
;
Qu, Wang
;
Shao, Guoliang
;
Shen, Feng
;
Song, Tianqiang
;
Song, Yan
;
Tao, Kaishan
;
Tian, Aiping
;
Wang, Jianhua
;
Wang, Wenling
;
Wang, Zhe
;
Wu, Liqun
;
Xia, Feng
;
Xing, Baocai
;
Xu, Jianming
;
Xue, Huadan
;
Yan, Dong
;
Yang, Lin
;
Ying, Jianming
;
Yun, Jingping
;
Zeng, Zhaochong
;
Zhang, Xuewen
;
Zhang, Yanqiao
;
Zhang, Yefan
;
Zhao, Jianjun
;
Zhou, Jianguo
;
Zhu, Xu
;
Zou, Yinghua
;
Dong, Jiahong
;
Fan, Jia
;
Lau, Wan Yee
;
Sun, Yan
;
Yu, Jinming
;
Zhao, Hong
;
Zhou, Aiping
;
Cai, Jianqiang
Favorite
  |  
View/Download:8/0
  |  
Submit date:2022/12/23
Chinese interdisciplinary experts
Hepatocellular carcinoma
Molecular targeted therapy
Consensus
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial
期刊论文
JAMA ONCOLOGY, 2021
Authors:
Lin, Yansong
;
Qin, Shukui
;
Li, Zhiyong
;
Yang, Hui
;
Fu, Wei
;
Li, Shaohua
;
Chen, Wenxin
;
Gao, Zairong
;
Miao, Weibing
;
Xu, Huiqin
;
Zhang, Qing
;
Zhao, Xinming
;
Bao, Jiandong
;
Li, Linfa
;
Ren, Yuan
;
Lin, Chenghe
;
Jing, Shanghua
;
Ma, Qingjie
;
Liang, Jun
;
Chen, Guang
;
Zhang, Hong
;
Zhang, Yifan
;
Zhou, Xianfeng
;
Sang, Yaxiong
;
Hou, Zhiguo
Favorite
  |  
View/Download:16/0
  |  
Submit date:2022/01/25
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
Authors:
Li, Jin
;
Qin, Shukui
;
Wen, Lu
;
Wang, Junsheng
;
Deng, Wenying
;
Guo, Weijian
;
Jia, Tongfu
;
Zhao, Qun
;
Zhang, Guifang
;
He, Yifu
;
Zhong, Haijun
;
Ba, Yi
;
Lin, Xiaoyan
;
Yang, Jianwei
;
Zhao, Jun
;
Bai, Yuxian
;
Sun, Guogui
;
Wu, Yongjuan
;
Wang, Meng
;
Sun, Ying
Favorite
  |  
View/Download:24/0
  |  
Submit date:2022/01/10
Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
Authors:
Qin, Shukui
;
Li, Jin
;
Zhong, Haijun
;
Jin, Chuan
;
Chen, Lili
;
Yuan, Xianglin
;
Fan, Qingxia
;
Chen, Kehe
;
Cao, Peiguo
;
Xiao, Jianjun
;
Jiang, Da
;
Zhang, Tao
;
Zhang, Hongyu
;
Wang, Xicheng
;
Wang, Wei
;
Wang, Qingyu
Favorite
  |  
View/Download:18/0
  |  
Submit date:2022/01/10
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
Authors:
Li, Jin
;
Qin, Shukui
;
Wen, Lu
;
Wang, Junsheng
;
Deng, Wenying
;
Guo, Weijian
;
Jia, Tongfu
;
Jiang, Da
;
Zhang, Guifang
;
He, Yifu
;
Zhong, Haijun
;
Ba, Yi
;
Lin, Xiaoyan
;
Yang, Jianwei
;
Zhao, Jun
;
Bai, Yuxian
;
Wu, Xiangyuan
;
Gao, Feng
;
Sun, Ying
;
Hou, Zhiguo
Favorite
  |  
View/Download:24/0
  |  
Submit date:2022/01/10